Concepedia

Drew Provan

DP

40

Publications

7.7K

Citations

26

H-Index

1996

Active since

Affiliations

Queen Mary University of London(Current)

Cornell University

Royal London Hospital

GlaxoSmithKline (United States)

Ospedale Regina Apostolorum

Drew Provan is an author at Queen Mary University of London specializing in medicine, hematology, and immunotherapy.

ORCID

Top concepts

Publications per year

1996–2024

40

Publications

40

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer et al. · Blood · 2008 · 2.6K citations · Full text

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan, Donald M. Arnold, James B. Bussel et al. · Blood Advances · 2019 · 1K citations · Full text

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 787 citations · Full text

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

James B. Bussel, Drew Provan, Tahir Shamsi et al. · The Lancet · 2009 · 537 citations

, , +8

The diagnosis and management of primary autoimmune haemolytic anaemia

Quentin A. Hill, R. Stamps, Edwin Massey et al. · British Journal of Haematology · 2016 · 250 citations · Full text

Rows per page

1–5 of 40